Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Coca-Cola Company (KO): How Its Earnings Are Saving the Dow Jones Industrial Average (.DJI)

Yesterday’s combination of horrible news, including the tragic explosion in Boston and troubling concerns on the economic front, left investors shaken. Yet this morning, the regular business of the market appeared to calm investors’ fears, as some favorable news on the earnings front helped investors refocus on signs of improvement for the U.S. economy. By 10:45 a.m. EDT, the Dow Jones Industrials were up more than 65 points, albeit putting only a small dent in yesterday’s 266-point drop. Broader markets saw similar gains of about half a percent.

The Coca-Cola Company

The big winner among the 30 Dow stocks is The Coca-Cola Company (NYSE:KO), which has spiked by more than 5% after releasing highly encouraging earnings. Although revenue dropped by 1%, overall sales volume posted a 4% gain, and the company’s adjusted earnings-per-share figure beat estimates by a penny despite some adverse calendar effects in comparison with last year’s quarter. Moreover, investors responded favorably to The Coca-Cola Company (NYSE:KO)’s decision to sell off some of its U.S. distribution assets to its team of independent bottlers. Although long-term trends may reassert themselves at some point, The Coca-Cola Company (NYSE:KO)’s news shows that counting the soft-drink giant out isn’t a smart move.

Johnson & Johnson (NYSE:JNJ) has also gained ground, rising 1.7% following an upbeat earnings report of its own. The company topped estimates by $0.04 per share, as the company’s prescription-drug and over-the-counter product lines performed well. Johnson & Johnson (NYSE:JNJ)even managed to overcome currency headwinds to post revenue growth of 8.5%. The company still faces problems, including weakness in medical-device sales and increased exposure to products liability in the wake of recent product recalls, but the rebound in consumer medications like Tylenol shows that customers are willing to forgive J&J’s past quality-control issues.

Outside the Dow, Delta Air Lines, Inc. (NYSE:DAL) has soared 3.5%. The latest figures from the Bureau of Labor Statistics showed that its consumer price index for airline fares rose by 0.6% during the month of March, reversing a slight decline in February and marking the sixth month in the past seven that prices have risen. With a year-over-year increase of 3.8%, fares are helping Delta Air Lines, Inc. (NYSE:DAL) and its peers keep their profits up, especially in light of the added revenue that baggage fees have brought to the industry.

The article How Coke’s Earnings Are Saving the Dow originally appeared on

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends Coca-Cola and Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.